Predominance of IncL/M and IncF plasmid types among CTX-M-ESBL-producing Escherichia coli and Klebsiella pneumoniae in Bulgarian hospitals

APMIS

Volumn 122, Issue 7, 2014, Pages 608-615

  Markovska, Rumyana ^a   Schneider, Ines ^b   Ivanova, Dobrinka ^c   Mitov, Ivan ^a   Bauernfeind, Adolf ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b MICOER Institute   (Germany)

^c Second Multiprofile Active Treatment Hospital   (Bulgaria)

Author keywords

CTX M; Enterobacteriaceae; IncF; IncL M; Replicon typing

Indexed keywords

AMIKACIN; BACTERIAL PROTEIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN INCF; PROTEIN INCL; PROTEIN INCM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BULGARIA; CONJUGATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MOLECULAR TYPING; NONHUMAN; PHYLOGENY; PLASMID; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; REPLICON; SCREENING;

CTX-M; ENTEROBACTERIACEAE; INCF; INCL/M; REPLICON TYPING;

BASE SEQUENCE; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BULGARIA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PLASMIDS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA;

EID: 84902835406     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12204     Document Type: Article

References (36)

1. Bradford P. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microb Rev 2001;14:933-51.
2. Coque T, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Eurosurveillance 2008;47:1-11.
3. Naseer U, Sundstjord A. The CTX-M conundrum: dissemination of plasmids and E. coli clones. Microbial Drug Resistance 2011;17:183-97.
4. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004;48:1-14.
5. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 1990;18:294-8.
6. Livermore D, Canton R, Gniadkowski M, Nordmann P, Rossolini G, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 2007;59:165-74.
7. Canton R, Coque T. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-75.
8. Karim A, Poirel L, Nagarajan S, Nordmann P. Plasmid-mediated extended-spectrum β-lactamases (CTX-M-3 like) from India and association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001;201:237-41.
9. Peirano G, Pitout J. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010;35:316-21.
10. Coque T, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008;14:195-200.
11. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009;53:2227-38.
12. Elhani D, Bakir L, Aouni M, Passet V, Arlet G, Brisse S, et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin Microbiol Infect 2010;16:157-64.
13. Naseer U, Haldorsen B, Tofteland S, Hegstad K, Scheutz F, Simonsen GS, et al. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway. APMIS 2009;117:526-36.
14. Mshana S, Imirzalioglu C, Hossain H, Hain T, Domann E, Chakraborty T. Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany. BMC Infect Dis 2009;17:97.
15. Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, et al. Replicon typing of plasmids in Escherichia coli producing extended-spectrum beta-lactamases. J Antimicrob Chemother 2009;63:67-71.
16. Hrabák J, Empel J, Bergerová T, Fajfrlík K, Urbásková P, Kern-Zdanowicz I, et al. International clones of Klebsiella pneumoniae and Escherichia coli with extended-spectrum beta-lactamases in a Czech hospital. J Clin Microbiol 2009;47:3353-7.
17. Gonullu N, Aktas Z, Kayacan C, Salcioglu M, Carattoli A, Yong D, et al. Dissemination of CTX-M-15 beta-lactamase genes carried on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey. J Clin Microbiol 2008;46:1110-2.
18. Carattoli A, García-Fernández A, Varesi P, Fortini D, Gerardi S, Penni A, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J Clin Microbiol 2008;46:103-8.
19. Novais A, Cantón R, Moreira R, Peixe L, Baquero F, Coque TM. Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob Agents Chemother 2007;51:796-9.
20. Hopkins K, Liebana E, Villa L, Batchelor M, Threlfall E, Carattoli A. Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother 2006;50:3203-6.
21. Keuleyan E, Kaludova V, Marinova R. Comparative susceptibility to beta-lactams and spectra of beta-lactamases in clinical Enterobacteriaceae strains. In: Program and Abstracts of the 4th Biennial Conference on Chemotherapy of Infectious Diseases and Malignancies (BICON). Prague, Czechoslovakia: FESCI, 1992 (abstract 217).
22. Markovska R, Schneider I, Keuleyan E, Sredkova M, Ivanova D, Markova B, et al. Extended-spectrum beta-lactamase producing Enterobacteriaceae in Bulgarian hospitals. Microb Drug Resist 2008;14:119-28.
23. Markovska R, Schneider I, Ivanova D, Keuleyan E, Stoeva T, Sredkova M, et al. High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals. Microb Drug Resist 2012;18:390-5.
24. th informational supplement. M100-S12. Wayne, PA: NCCLS, 2007.
25. Jarlier V, Nicolas M, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.
26. Matthew M, Harris A, Marshall M, Ross G. The use of analytical isoelectric focussing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169-78.
27. Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U. A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae causing nosocomial pneumonia. Antimicrob Agents Chemother 1999;43:1924-31.
28. Versalovic J, Koeuth T, Lupski J. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991;19:6823-31.
29. Clermont O, Bonacorsi S, Bingen E. Rapid and simple detection of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555-8.
30. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, et al. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 2009;64:274-7.
31. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins K, Threlfall E. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005;63:219-28.
32. Baraniak A, Fiett J, Hryniewicz W, Nordmann P, Gniadkowski M. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J Antimicrob Chemother 2002;50:393-6.
33. Nicolas-Chanoine M, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça M, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61:273-81.
34. Sabtcheva S, Saga T, Kantardjiev T, Ivanova M, Ishii Y, Kaku M. Nosocomial spread of armA-mediated high-level aminoglycoside resistance in Enterobacteriaceae isolates producing CTX-M-3 beta-lactamase in a cancer hospital in Bulgaria. J Chemother 2008;20:593-9.
35. Empel J, Baraniak A, Literacka E, Mrówka A, Fiett J, Sadowy E, et al. Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 2008;52:2449-54.
36. Naumiuk L, Baraniak A, Gniadkowski M, Krawczyk B, Rybak B, Sadowy E, et al. Molecular epidemiology of Serratia marcescens in two hospitals in Gdansk, Poland, over a 5-year period. J Clin Microbiol 2004;42:3108-16.